INTERESTED IN THIS RESEARCH?
Contact our analysts for inquiries, samples, and expert insights.
REPORT OUTLOOK
| Market Size | CAGR | Dominating Region |
|---|---|---|
| USD 308.47 million | 6.3% | Asia Pacific |
| By Product & Technology | By Indication | By Application |
|---|---|---|
|
|
|
SCOPE OF THE REPORT
Us Therapeutic Plasma Exchange Market Overview
The global US therapeutic plasma exchange market is expected to grow at more than 6.3% CAGR from 2022 to 2029. It is expected to reach above USD 308.47 million by 2029 from USD 178 million in 2020.
The expansion of this market is propelled by the increasing prevalence of chronic illnesses and advancements in technology. However, factors such as the elevated expenses associated with apheresis devices and therapeutic plasma exchange procedures, as well as the adoption of a rental model for apheresis device installation, are anticipated to impede market growth to some extent throughout the forecast period.
Continuous-flow centrifugation technology represents a sophisticated method that has undergone refinement over the past decade. It introduces innovations aimed at enhancing patient comfort and optimizing the processing of blood and plasma products. This technology necessitates minimal blood flow in comparison to alternative methodologies, such as membrane separation approaches.
Notably, it represents an enhanced technology facilitating easier access to blood via the patient’s peripheral veins, such as the antecubital or brachial veins, as opposed to membrane-based apheresis devices, which often require invasive central venous catheterization. These technical advancements additionally contribute to heightened patient comfort and safety during therapeutic plasma exchange procedures, enabling more precise fluid balance control for improved hemodynamic stability during treatment.
The increasing adoption of therapeutic plasma exchange for treating various ailments is poised to present promising growth prospects for market participants in the forthcoming years. Therapeutic plasma exchange (TPE) finds application in addressing neurological, hematological, renal, and autoimmune disorders characterized by known or suspected immune pathogenesis. However, the utilization of therapeutic plasma exchange procedures in pediatric patients remains limited, although it is progressively gaining traction in pediatric nephrology due to technological advancements. Noteworthy progress in technology has facilitated the execution of TPE procedures in pediatric patients to address renal diseases.
Us Therapeutic Plasma Exchange Market Segment Analysis
The therapeutic plasma exchange market in the United States has been divided into two segments based on technology: centrifugation and membrane separation. In 2019, the segment of centrifugation technology accounted for the lion’s share of the therapeutic plasma exchange market in the United States The advantages of centrifugation over membrane separation, such as high efficiency and the capacity to separate all types of blood components, account for a considerable part of this category. The therapeutic plasma exchange market in the United States has been classified into neurological illnesses, renal disorders, hematologic disorders, metabolic disorders, and other indications.
The therapeutic plasma exchange market in the United States has been divided into two categories: devices and consumables. During the predicted period, the consumables category will expand the most. The repeated usage of these products, the increasing frequency of therapeutic plasma exchange operations, and advantageous reimbursement rules for TPE treatments are driving the fastest growth in this market.
The neurological disorders segment accounted for the lion’s share of the therapeutic plasma exchange market in the United States. The rising prevalence and incidence of neurological diseases in the geriatric population, rising awareness about the treatment of neurological diseases using plasma exchange, and rising investments by key players in R&D on new application areas of therapeutic plasma exchange in the treatment of neurological disorders are driving growth in this market.The blood collection facilities and blood component providers segment is predicted to account for the majority of the therapeutic plasma exchange market in the United States.
The therapeutic plasma exchange market in the United States has been divided into two categories: devices and consumables. During the predicted period, the consumables category will expand the most. The high prevalence of these goods, the growing number of therapeutic plasma exchange operations, and advantageous reimbursement rules for TPE treatments all contribute to the segment’s size.
The therapeutic plasma exchange market in the United States has been divided into two segments based on technology: centrifugation and membrane separation. In 2019, the centrifugation technique category accounted for the lion’s share of the therapeutic plasma exchange market in the United States. The advantages of centrifugation over membrane separation, such as high efficiency and the capacity to separate all types of blood components, account for a considerable part of this category.
The therapeutic plasma exchange market in the United States has been divided into three segments based on end-user: blood collection centers and blood component providers, hospitals and transfusion centers, and other end users. In 2019, the blood collection centers and blood component providers segment accounted for the majority of the therapeutic plasma exchange market in the United States. The expanding number of blood component contributions, the growing number of blood centers, and the rising number of therapeutic plasma exchange procedures and plasma donations as a result of COVID-19 all contribute to the substantial share of this end-user category.
Us Therapeutic Plasma Exchange Market Key Players
The prominent players in the US therapeutic plasma exchange market are Terumo BCT, Inc. (US), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Asahi Kasei Medical Co. Ltd. (Japan), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Cerus Corporation (US), Kaneka Corporation (Japan), Kawasumi Laboratories, Inc. (Japan), Nikkiso Co., Ltd. (Japan), Miltenyi Biotec (Germany), Medica S.p.A. (Italy), Medicap Clinic GmbH (Germany), and Infomed (Switzerland).
Who Should Buy? Or Key Stakeholders
- Investors
- Environment, Health and Safety Professionals
- Research Organizations
- Healthcare industry
- Regulatory Authorities
- Others
Us Therapeutic Plasma Exchange Market Regional Analysis
The US therapeutic plasma exchange market is divided into major regions- North America, Europe, South America, Asia Pacific, and middle east & Africa. North America is the largest regional segment in 2021. The growing penetration of electric cars was the primary factor driving product demand. Furthermore, the growing regulatory support for reducing vehicular emissions projected to have a favorable impact on growth.
- North America: includes the US, Canada, Mexico
- Europe: includes UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe
- Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
- South America: includes Brazil, Argentina and Rest of South America
- Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA
Throughout the projected period, North America is expected to dominate the total therapeutic plasma exchange systems market. The dominance is due to an increase in the global prevalence of various autoimmune disorders, as well as a rapid increase in the use of lipoprotein apheresis for cardiovascular indications such as CAD, hypercholesterolemia strokes, and atherosclerosis, as well as an increase in the rate of cardiac deaths in recent years. According to The American Heart Association, roughly 92.1 million people in the United States suffered from cardiovascular disorders in 2018, resulting in increased demand for TPE driving the market in the region. Furthermore, growing availability of modern technologies and developed healthcare infrastructures in the region is expected to propel the market throughout the forecast period. Due to exchange procedures and plasma donations.
Key Market Segments: Global US Therapeutic Plasma Exchange Market
US Therapeutic Plasma Exchange Market By Product & Technology, 2020-2029, (USD Million)
- Devices
- Consumable
- Centrifugation
- Membrane Separation
US Therapeutic Plasma Exchange Market By Indication, 2020-2029, (USD Million)
- Neurology Disorder
- Hematology Disorder
- Renal Disorder
- Metabolic Disorder
US Therapeutic Plasma Exchange Market By Application, 2020-2029, (USD Million)
- Blood Collection Centers
- Blood Component Providers
- Hospital & Transfusion Centers
US Therapeutic Plasma Exchange Market By Region, 2020-2029, (USD Million)
- North America
- Europe
- Asia Pacific
- South America
- Middle East And Africa
Important countries in all regions are covered (total country profiles 25)
Objectives Of The Study
- To provide an overall view of the market.
- To detail key pointers such as growth, market size, trends, drivers, restraints, challenges and opportunities in quantitative and qualitative terms
- To provide a holistic view of market players and their activities to get an understanding of key growth strategies adopted
- The global US therapeutic plasma exchange market is expected to grow at more than 6.3% CAGR
- Based on products and technology, the segment of centrifugation technology accounted for the major share of the therapeutic plasma exchange market in the United States.
- Based on indication, neurology disorder has the dominating share.
- Based on application, Blood Collection Centers has the dominating share.
- North America is expected to dominate the total therapeutic plasma exchange systems market.
- The major trend in the US Therapeutic Plasma Exchange Market is the increasing adoption of advanced automation technologies for plasma exchange procedures.
Key Question Answered
- What is the current market size of this high-growth market?
- What is the overall growth rate?
- What are the key growth areas, types, Applications?
- Key reasons for the growth
- Challenges for growth
- What technological developments are happening in this area?
Table of Content
- Introduction
- Market Definition
- Market Segmentation
- Research Timelines
- Assumptions and Limitations
- Research Methodology
- Data Mining
- Secondary Research
- Primary Research
- Subject-Matter Experts’ Advice
- Quality Checks
- Final Review
- Data Triangulation
- Bottom-Up Approach
- Top-Down Approach
- Research Flow
- Data Sources
- Data Mining
- Executive Summary
- Market Overview
- Global US Therapeutic Plasma Exchange Market Outlook
- Market Drivers
- Market Restraints
- Market Opportunities
- Impact of Covid-19 On US Therapeutic Plasma Exchange Market
- Porter’s five forces model
- Threat from new entrants
- Threat from substitutes
- Bargaining power of suppliers
- Bargaining power of customers
- Degree of competition
- Industry value chain Analysis
- Global US Therapeutic Plasma Exchange Market Outlook
- Global US Therapeutic Plasma Exchange Market by Product & Technology & Technology& Technology, (USD Million)
- Devices
- Consumable
- Centrifugation
- Membrane separation
- Global US Therapeutic Plasma Exchange Market by Indication, (USD Million)
- Devices
- Consumable
- Centrifugation
- Membrane separation
- Global US Therapeutic Plasma Exchange Market by Application (USD Million)
- Hospital
- Labs
- Homecare
- Global US Therapeutic Plasma Exchange Market by Region
- North America
- US
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Colombia
- Rest Of South America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest Of Europe
- Asia Pacific
- India
- China
- Japan
- South Korea
- Australia
- South-East Asia
- Rest Of Asia Pacific
- Middle East and Africa
- UAE
- Saudi Arabia
- South Africa
- Rest Of Middle East and Africa
- North America
- Company Profiles*(Business Overview, Company Snapshot, Products Offered, Recent Developments)
-
- Terumo BCT, Inc.
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- Asahi Kasei Medical Co. Ltd.
- Braun Melsungen AG
- Baxter International Inc.
- Cerus Corporation
- Kaneka Corporation
- Kawasumi Laboratories, Inc.
- Nikkiso Co., Ltd.
- Miltenyi Biotec
- Medica S.p.A.
- Medicap Clinic GmbH
- Infomed Others
*The Company List Is Indicative
Â
LIST OF TABLES
TABLE 1Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY(USD MILLIONS) 2020-2029
TABLE 2Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY 2020-2029
TABLE 3Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION(USD MILLIONS) 2020-2029
TABLE 4Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION 2020-2029
TABLE 5Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 6Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATIONÂ 2020-2029
TABLE 7Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL US THERAPEUTIC PLASMA EXCHANGE MARKET BY REGION (USD MILLIONS) 2020-2029
TABLE 8Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL US THERAPEUTIC PLASMA EXCHANGE MARKET BY REGIONÂ 2020-2029
TABLE 9Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â US US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY(USD MILLIONS) 2020-2029
TABLE 10Â Â Â Â Â Â Â Â Â Â Â Â Â US US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY 2020-2029
TABLE 11Â Â Â Â Â Â Â Â Â Â Â Â Â US US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION(USD MILLIONS) 2020-2029
TABLE 12Â Â Â Â Â Â Â Â Â Â Â Â Â US US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION 2020-2029
TABLE 13Â Â Â Â Â Â Â Â Â Â Â Â Â US US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 14Â Â Â Â Â Â Â Â Â Â Â Â Â US US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATIONÂ 2020-2029
TABLE 15Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY(USD MILLIONS) 2020-2029
TABLE 16Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY 2020-2029
TABLE 17Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION(USD MILLIONS) 2020-2029
TABLE 18Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION 2020-2029
TABLE 19Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 20Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATIONÂ 2020-2029
TABLE 21Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY(USD MILLIONS) 2020-2029
TABLE 22Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY 2020-2029
TABLE 23Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION(USD MILLIONS) 2020-2029
TABLE 24Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION 2020-2029
TABLE 25Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 26Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATIONÂ 2020-2029
TABLE 27Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY(USD MILLIONS) 2020-2029
TABLE 28Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY 2020-2029
TABLE 29Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION(USD MILLIONS) 2020-2029
TABLE 30Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION 2020-2029
TABLE 31Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 32Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATIONÂ 2020-2029
TABLE 33Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY(USD MILLIONS) 2020-2029
TABLE 34Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY 2020-2029
TABLE 35Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION(USD MILLIONS) 2020-2029
TABLE 36Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION 2020-2029
TABLE 37Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 38Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATIONÂ 2020-2029
TABLE 39Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY(USD MILLIONS) 2020-2029
TABLE 40Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY 2020-2029
TABLE 41Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION(USD MILLIONS) 2020-2029
TABLE 42Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION 2020-2029
TABLE 43Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 44Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATIONÂ 2020-2029
TABLE 45Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY(USD MILLIONS) 2020-2029
TABLE 46Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY 2020-2029
TABLE 47Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION(USD MILLIONS) 2020-2029
TABLE 48Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION 2020-2029
TABLE 49Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 50Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATIONÂ 2020-2029
TABLE 51Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY(USD MILLIONS) 2020-2029
TABLE 52Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY 2020-2029
TABLE 53Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION(USD MILLIONS) 2020-2029
TABLE 54Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION 2020-2029
TABLE 55Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 56Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY END-USERÂ 2020-2029
TABLE 57Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY(USD MILLIONS) 2020-2029
TABLE 58Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY 2020-2029
TABLE 59Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION(USD MILLIONS) 2020-2029
TABLE 60Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION 2020-2029
TABLE 61Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 62Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATIONÂ 2020-2029
TABLE 63Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY(USD MILLIONS) 2020-2029
TABLE 64Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY 2020-2029
TABLE 65Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION(USD MILLIONS) 2020-2029
TABLE 66Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION 2020-2029
TABLE 67Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 68Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATIONÂ 2020-2029
TABLE 69Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY(USD MILLIONS) 2020-2029
TABLE 70Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY 2020-2029
TABLE 71Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION(USD MILLIONS) 2020-2029
TABLE 72Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION 2020-2029
TABLE 73Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREAÂ m MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 74Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATIONÂ 2020-2029
TABLE 75Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY(USD MILLIONS) 2020-2029
TABLE 76Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY 2020-2029
TABLE 77Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION(USD MILLIONS) 2020-2029
TABLE 78Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION 2020-2029
TABLE 79Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 80Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATIONÂ 2020-2029
TABLE 81Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY(USD MILLIONS) 2020-2029
TABLE 82Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY 2020-2029
TABLE 83Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION(USD MILLIONS) 2020-2029
TABLE 84Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION 2020-2029
TABLE 85Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 86Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATIONÂ 2020-2029
TABLE 87Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY(USD MILLIONS) 2020-2029
TABLE 88Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY 2020-2029
TABLE 89Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION(USD MILLIONS) 2020-2029
TABLE 90Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION 2020-2029
TABLE 91Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 92Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATIONÂ 2020-2029
TABLE 93Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY(USD MILLIONS) 2020-2029
TABLE 94Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY 2020-2029
TABLE 95Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION(USD MILLIONS) 2020-2029
TABLE 96Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION 2020-2029
TABLE 97Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 98Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATIONÂ 2020-2029
TABLE 99Â Â Â Â Â Â Â Â Â Â Â Â Â UK US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY(USD MILLIONS) 2020-2029
TABLE 100Â Â Â Â Â Â Â Â Â Â Â UK US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY 2020-2029
TABLE 101Â Â Â Â Â Â Â Â Â Â Â UK US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION(USD MILLIONS) 2020-2029
TABLE 102Â Â Â Â Â Â Â Â Â Â Â UK US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION 2020-2029
TABLE 103Â Â Â Â Â Â Â Â Â Â Â UK US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 104Â Â Â Â Â Â Â Â Â Â Â UK US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATIONÂ 2020-2029
TABLE 105Â Â Â Â Â Â Â Â Â Â Â FRANCE US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY(USD MILLIONS) 2020-2029
TABLE 106Â Â Â Â Â Â Â Â Â Â Â FRANCE US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY 2020-2029
TABLE 107Â Â Â Â Â Â Â Â Â Â Â FRANCE US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION(USD MILLIONS) 2020-2029
TABLE 108Â Â Â Â Â Â Â Â Â Â Â FRANCE US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION 2020-2029
TABLE 109Â Â Â Â Â Â Â Â Â Â Â FRANCE US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 110Â Â Â Â Â Â Â Â Â Â Â FRANCE US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATIONÂ 2020-2029
TABLE 111Â Â Â Â Â Â Â Â Â Â Â ITALY US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY(USD MILLIONS) 2020-2029
TABLE 112Â Â Â Â Â Â Â Â Â Â Â ITALY US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY 2020-2029
TABLE 113Â Â Â Â Â Â Â Â Â Â Â ITALY US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION(USD MILLIONS) 2020-2029
TABLE 114Â Â Â Â Â Â Â Â Â Â Â ITALY US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION 2020-2029
TABLE 115Â Â Â Â Â Â Â Â Â Â Â ITALY US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 116Â Â Â Â Â Â Â Â Â Â Â ITALY US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATIONÂ 2020-2029
TABLE 117Â Â Â Â Â Â Â Â Â Â Â SPAIN US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY(USD MILLIONS) 2020-2029
TABLE 118Â Â Â Â Â Â Â Â Â Â Â SPAIN US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY 2020-2029
TABLE 119Â Â Â Â Â Â Â Â Â Â Â SPAIN US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION(USD MILLIONS) 2020-2029
TABLE 120Â Â Â Â Â Â Â Â Â Â Â SPAIN US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION 2020-2029
TABLE 121Â Â Â Â Â Â Â Â Â Â Â SPAIN US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 122Â Â Â Â Â Â Â Â Â Â Â SPAIN US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATIONÂ 2020-2029
TABLE 123Â Â Â Â Â Â Â Â Â Â Â RUSSIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY(USD MILLIONS) 2020-2029
TABLE 124Â Â Â Â Â Â Â Â Â Â Â RUSSIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY 2020-2029
TABLE 125Â Â Â Â Â Â Â Â Â Â Â RUSSIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION(USD MILLIONS) 2020-2029
TABLE 126Â Â Â Â Â Â Â Â Â Â Â RUSSIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION 2020-2029
TABLE 127Â Â Â Â Â Â Â Â Â Â Â RUSSIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 128Â Â Â Â Â Â Â Â Â Â Â RUSSIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATIONÂ 2020-2029
TABLE 129Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY(USD MILLIONS) 2020-2029
TABLE 130Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY 2020-2029
TABLE 131Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION(USD MILLIONS) 2020-2029
TABLE 132Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION 2020-2029
TABLE 133Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 134Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATIONÂ 2020-2029
TABLE 135Â Â Â Â Â Â Â Â Â Â Â UAE US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY(USD MILLIONS) 2020-2029
TABLE 136Â Â Â Â Â Â Â Â Â Â Â UAE US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY 2020-2029
TABLE 137Â Â Â Â Â Â Â Â Â Â Â UAE US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION(USD MILLIONS) 2020-2029
TABLE 138Â Â Â Â Â Â Â Â Â Â Â UAE US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION 2020-2029
TABLE 139Â Â Â Â Â Â Â Â Â Â Â UAE US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 140Â Â Â Â Â Â Â Â Â Â Â UAE US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATIONÂ 2020-2029
TABLE 141Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY(USD MILLIONS) 2020-2029
TABLE 142Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY 2020-2029
TABLE 143Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION(USD MILLIONS) 2020-2029
TABLE 144Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION 2020-2029
TABLE 145Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 146Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATIONÂ 2020-2029
TABLE 147Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY(USD MILLIONS) 2020-2029
TABLE 148Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY 2020-2029
TABLE 149Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION(USD MILLIONS) 2020-2029
TABLE 150Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION 2020-2029
TABLE 151Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 152Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATIONÂ 2020-2029
TABLE 153Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY(USD MILLIONS) 2020-2029
TABLE 154Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA US THERAPEUTIC PLASMA EXCHANGE MARKET BY PRODUCT & TECHNOLOGY 2020-2029
TABLE 155Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION(USD MILLIONS) 2020-2029
TABLE 156Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA US THERAPEUTIC PLASMA EXCHANGE MARKET BY INDICATION 2020-2029
TABLE 157Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 158Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATIONÂ 2020-2029
LIST OF FIGURES
FIGURE 1Â Â Â Â Â Â Â MARKET DYNAMICS
FIGURE 2Â Â Â Â Â Â Â MARKET SEGMENTATION
FIGURE 3Â Â Â Â Â Â Â REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4Â Â Â Â Â Â Â DATA TRIANGULATION
FIGURE 5Â Â Â Â Â Â Â BOTTOM-UP APPROACH
FIGURE 6Â Â Â Â Â Â Â TOP-DOWN APPROACH
FIGURE 7Â Â Â Â Â Â Â RESEARCH FLOW
FIGURE 8Â Â Â Â Â Â Â GLOBAL US THERAPEUTIC PLASMA EXCHANGE MARKET BY VEHICLE TYPE, USD MILLION, 2020-2029
FIGURE 9Â Â Â Â Â Â Â GLOBAL US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATION, USD MILLION, 2020-2029
FIGURE 10Â Â Â Â GLOBAL US THERAPEUTIC PLASMA EXCHANGE MARKET BY APPLICATION, USD MILLION, 2020-2029
FIGURE 11Â Â Â Â GLOBAL US THERAPEUTIC PLASMA EXCHANGE MARKET BY REGION, USD MILLION, 2020-2029
FIGURE 12          PORTER’S FIVE FORCES MODEL
FIGURE 13Â Â Â Â Â Â Â Â Â Â NORTH AMERICA US THERAPEUTIC PLASMA EXCHANGE MARKET SNAPSHOT
FIGURE 14Â Â Â Â Â Â Â Â Â Â EUROPE US THERAPEUTIC PLASMA EXCHANGE MARKET SNAPSHOT
FIGURE 15Â Â Â Â Â Â Â Â Â Â ASIA PACIFIC US THERAPEUTIC PLASMA EXCHANGE MARKET SNAPSHOT
FIGURE 16Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA US THERAPEUTIC PLASMA EXCHANGE MARKET SNAPSHOT
FIGURE 17Â Â Â Â Â Â Â Â Â Â MIDDLE EAST & AFRICA US THERAPEUTIC PLASMA EXCHANGE MARKET SNAPSHOT
FIGURE 18Â Â Â Â Â Â Â Â Â Â FRESENIUS SE & CO. KGAA: COMPANY SNAPSHOT
FIGURE 19Â Â Â Â Â Â Â Â Â Â HAEMONETICS CORPORATION: COMPANY SNAPSHOT
FIGURE 20Â Â Â Â Â Â Â Â Â Â ASAHI KASEI MEDICAL CO. LTD.: COMPANY SNAPSHOT
FIGURE 21Â Â Â Â Â Â Â Â Â Â B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
FIGURE 22Â Â Â Â Â Â Â Â Â Â BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
FIGURE 23Â Â Â Â Â Â Â Â Â Â CERUS CORPORATION: COMPANY SNAPSHOT
FIGURE 24Â Â Â Â Â Â Â Â Â Â KANEKA CORPORATION: COMPANY SNAPSHOT
FIGURE 25Â Â Â Â Â Â Â Â Â Â KAWASUMI LABORATORIES, INC.: COMPANY SNAPSHOT
FIGURE 26Â Â Â Â Â Â Â Â Â Â NIKKISO CO., LTD.: COMPANY SNAPSHOT
FIGURE 27Â Â Â Â Â Â Â Â Â Â MILTENYI BIOTEC: COMPANY SNAPSHOT
FIGURE 27Â Â Â Â Â Â Â Â Â Â MEDICA S.P.A. : COMPANY SNAPSHOT
FIGURE 28Â Â Â Â Â Â Â Â Â Â MEDICAP CLINIC GMBH : COMPANY SNAPSHOT
FIGURE 29Â Â Â Â Â Â Â Â Â Â INFOMED : COMPANY SNAPSHOT
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.